WednesdayJun 17, 2026 10:00 am

Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy

Researchers at Northwestern Medicine have identified immune system markers that may help predict who responds to BCG bladder cancer therapy and who does not. The Journal of Clinical Investigation published the findings.  The study centers on Bacillus Calmette-Guérin (BCG) for non-muscle-invasive bladder cancer, a cancer affecting the bladder lining, and why the therapy fails for some patients. What determines whether BCG succeeds or fails for any given patient has never been fully explained. BCG functions by exposing the body to a weakened form of bacteria, triggering the immune system to mount a response.  Despite its long history as a front-line treatment, researchers have remained uncertain about why some patients benefit significantly while others do not.…

Continue Reading

TuesdayJun 16, 2026 9:00 am

Frontieras North America Inc. Unlocks the Untapped Value of America’s Coal Reserves

Despite decades of energy innovation, coal remains one of the largest and most accessible energy resources in the world. Frontieras’s position is straightforward: Coal is not obsolete; it is underutilized. FASForm(TM) thermally fractionates coal into multiple commercial outputs, including diesel, jet fuel, naphtha, hydrogen, purified industrial carbon and fertilizer-related products. Coal has powered economies, industries and infrastructure for generations, yet much of its potential remains untapped. Frontieras North America is advancing a new approach to coal utilization through its proprietary FASForm platform, a patented process that converts coal into fuels, hydrogen and industrial materials, positioning one of America’s most abundant resources as a…

Continue Reading

MondayJun 15, 2026 10:00 am

IEA Warns That Coal Investment Has Reached 14-Year Record

Coal investment has climbed to levels unseen since the early 2010s, a troubling reversal for climate advocates worldwide. The International Energy Agency projects spending will hit $180 billion by the end of 2026, representing a 4% jump from 2025 investment levels. This suggests fossil fuels remain deeply entrenched in global energy strategies despite renewable energy's rapid expansion.  China and India dominate this spending surge in ways that reshape the global energy landscape. China alone accounts for more than two-thirds of worldwide coal investment, with steam coal production funding alone approaching $100 billion annually, roughly double what was spent a decade ago.  India is the second major investor, having tripled coal spending over the past 10 years…

Continue Reading

WednesdayJun 10, 2026 10:00 am

Microsoft to Have Scalable Quantum Computer by 2029

Microsoft has pulled forward its target date for building a practical quantum computer from 2033 to 2029, crediting a major jump in chip performance. Zulfi Alam, Microsoft's VP for quantum, announced the new target last week alongside the launch of Majorana 2, the follow-on to Majorana 1.  Majorana 1 was released in early 2025, and Majorana 2 builds on it as Microsoft edges toward hardware that outstrips conventional machines. A practical quantum machine would tackle classes of problems that conventional computers cannot crack within any useful timeframe.  Majorana 2 qubits hold their state for about 20 seconds, roughly 1,000 times longer than its predecessor. Keeping qubits stable is a core challenge because they are inherently fragile and easily knocked off course by their…

Continue Reading

MondayJun 08, 2026 10:00 am

Collagen Tiles Could Prevent Brain Cancer Recurrence

A clinical trial has found that placing radioactive tiles into the brain cavity at tumor removal dramatically cuts recurrence and extends survival. The ROADS trial, led by MD Anderson Cancer Center, was presented at the 2026 American Society of Clinical Oncology meeting.  It is the first randomized Phase 3 study to directly compare this approach with postoperative stereotactic radiation therapy, conducted across multiple centers. The study was sponsored by GT Medical Technologies, maker of the FDA-cleared brachytherapy device used in the trial.  Left untreated with radiation, the surgical cavity shows regrowth in 50% to 60% of patients, making some form of postoperative treatment essential. One year after…

Continue Reading

MondayJun 08, 2026 9:00 am

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) Is ‘One to Watch’

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) and may include paid advertising. Redwood AI is developing a proprietary AI platform designed to support drug discovery, synthesis planning, and chemical analysis across pharmaceutical, public safety, defense, and industrial-related markets. The company is positioned across multiple large global market opportunities, including pharmaceutical development, defense-related chemical intelligence, AI-assisted drug discovery, and CDMO infrastructure applications. Reactosphere combines synthesis planning, optimization workflows, sourcing intelligence, and chemical analysis capabilities within a single AI-driven platform. Redwood AI is advancing its AI-powered chemistry platform through research collaborations and government-supported initiatives involving organizations including UBC,…

Continue Reading

WednesdayJun 03, 2026 10:00 am

New Pill Offers Hope Against Pancreatic Cancer 

A new pill can reportedly double survival in early pancreatic cancer trials, raising cautious optimism about a disease that has long resisted treatment. Revolution Medicines' daraxonrasib targets KRAS, a gene that supplies instructions for the development of the K-Ras protein which is essentially a switch for controlling cell division, growth, and death.  Daraxonrasib belongs to a class of targeted therapies dubbed RAS inhibitors, designed to act on the KRAS gene and disrupt a genetic mutation found across multiple cancer types. The biotech company behind the novel treatment will release its full Phase 3 results at the upcoming American Society of Clinical Oncology meeting.  Pancreatic cancer has a…

Continue Reading

MondayJun 01, 2026 10:30 am

Frontieras North America Inc. Reimagines Coal for the AI Economy

The rapid rise of AI is already reshaping electricity consumption worldwide. Frontieras’ proprietary FASForm technology processes coal into multiple high-value outputs rather than using it solely for combustion. The company also focuses on infrastructure compatibility. Artificial intelligence (“AI”) is transforming the way the world uses energy. From massive data centers to advanced manufacturing systems, the technologies powering the AI boom require enormous amounts of reliable electricity, putting growing pressure on existing energy infrastructure. Frontieras North America is positioning itself within that shift through its proprietary FASForm(TM) platform, which converts coal into fuels, hydrogen and industrial products, changing one of the world’s most abundant resources…

Continue Reading

MondayJun 01, 2026 10:00 am

Limited Storage Hampers Renewable Energy in Europe

Due to the intermittent nature inherent to most sources of renewable energy, storage infrastructure will be critical to the transition to clean energy. Such facilities allow renewable energy providers to store energy produced in peak generation hours and disburse it when demand peaks. However, with Europe boasting limited energy storage infrastructure, the continent’s efforts to move away from fossil fuels effectively are being hampered. Consequently, investing in storage infrastructure could help European nations shake off their reliance on fossil fuels at a more accelerated pace. Renewable energy sources like solar and wind are capable of producing large amounts of clean…

Continue Reading

Contact us: (512) 354-7000